Inactivation of MGMT before dosing with an O6-alkylating agent considerably enhances the anti-tumour activity of the latter drug in vitro and in animal tumour models (Dolan et al, 1990; Karran and Bignami, 1994; Friedman et al, 2002). This evidence concerns the gene MGMT and neoplasm.